 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kazia Therapeutics Ltd. is a clinical stage oncology company It engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Current Price	$1.17
Prev Close	$1.26
Open	$1.22
Dividend Yield	0.00%
50-Day Moving Average	$1.21
Beta	0.83
Avg. Volume	59,818.37
PE Ratio	-0.93

52-Week High	$6.38
52-Week Low	$0.5004
Market Capitalization	$26.68M
EPS	-$1.25
Price to Book	2.43
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-0.39

KZIA Kazia Therapeutics

About

Feed

Fundamentals

News